Crossover Study of Safety and Tolerability of Two Formulations of Adalimumab.
Clinical trial NCT01561313 · COMPLETED
Trial details
- NCT number
- NCT01561313
- Sponsor
- AbbVie (prior sponsor, Abbott)
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2012-03-01
- Primary completion
- 2012-11-01
- Enrollment
- 64
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.